Physician profile
David A Baer
NPI 1962411280
$25,849.40
in general payments reported to CMS, 2019-2025
21 companies · $9,757 in 2025
The $9,757 reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $528 · 2020: $37.72 · 2021: $905 · 2022: $813 · 2023: $8,162 · 2024: $5,648 · 2025: $9,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,500 · Education: $5,500 · Food and Beverage: $5,482 · Travel and Lodging: $3,059 · Gift: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,500.00 |
| Education | $5,500.00 |
| Food and Beverage | $5,482.33 |
| Travel and Lodging | $3,059.35 |
| Gift | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $15,897.53 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Intuitive Surgical, INC. | $8,875.36 | 2019-2025 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Stryker Corporation | $435.84 | 2019-2023 | Spy-Phi System |
| Z-Medica, LLC | $92.58 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.64 | 2021-2022 | |
| Kerecis Limited | $65.61 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Innovation Technologies INC | $50.84 | 2024-2025 | Irrisept |
| Conmed Corporation | $47.62 | 2023 | Airseal |
| Aroa Biosurgery Incorporated | $44.82 | 2022-2024 | |
| Vertex Pharmaceuticals Incorporated | $37.55 | 2025 | |
| Ethicon US, LLC | $27.26 | 2022 | |
| Becton, Dickinson and Company | $25.62 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $25.46 | 2022 | |
| Allergan, INC. | $22.93 | 2020 | |
| Convatec INC. | $22.41 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $22.17 | 2021 | |
| Acell, INC. | $19.99 | 2019 | |
| Abbvie INC. | $18.39 | 2022 | |
| Bolder Surgical, LLC | $17.15 | 2022 | |
| Covidien LP | $14.79 | 2020 | |
| Boston Scientific Corporation | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Baer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.